Hydrops fetalis and neonatal death from human parvovirus B19: an unusual complication.
A case of prenatally diagnosed human parvovirus B19 (HPVB19) infection is reported. The neonate died after intrauterine therapy and premature delivery. The fetus was diagnosed with oedema, cardiomegaly, poor myocardial contractility and a pericardial effusion at 24/40 weeks' gestation. Ultrasound using colour flow Doppler showed a midcerebral artery peak systolic velocity (MCA PSV) raised at 45 cm/s, suggesting fetal anaemia. This was confirmed on fetal blood sampling, but recovery was suggested with a reticulocyte count of 16.8%. The fetal karyotype was normal, 46,XY. Fetal IgM was positive for Parvovirus. A week later, severe fetal anaemia was suspected and intrauterine transfusion carried out. Altogether three transfusions were given. At 31/40 weeks, the mother presented to her local hospital with suspected preterm labour, a caesarean section was carried out because of fetal compromise on cardiotocography. The baby was in poor condition at birth and resuscitation was stopped at 45 min of age. The post-mortem examination confirmed the hydrops and proved persistent Parvovirus infection, cardiac involvement and severe liver fibrosis.HPVB19 generally follows a benign course with intrauterine therapy; however, in this case, the fetus died despite successful transfusions. The reasons for this are discussed.
Marton
T
T
Department of Histopathology Birmingham Women's Hospital, Edgbaston, Birmingham, UK. tamas.marton@bwhct.nhs.uk
Martin
W L
WL
Whittle
M J
MJ
D000328:Adult; D000740:Anemia / Q000175:diagnosis / Q000196:embryology / Q000473:pathology / Q000628:therapy; D001805:Blood Transfusion, Intrauterine; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature; D010322:Parvoviridae Infections / Q000175:diagnosis* / Q000196:embryology / Q000473:pathology / Q000628:therapy; D016732:Parvovirus B19, Human; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011296:Prenatal Diagnosis